Jennifer J. Cory, MA2, CRA
Director of Operations
Ms Cory has over 18 years of experience in management and operations in the academic setting and her career spans the pre-award, post-award, and compliance areas of research administration. At Stanford, she has extensive experience working with faculty in pediatrics, blood and marrow transplantation and stem cell biology and regenerative medicine. The most recent past position she held was as Director of Research Administration in the Department of Pediatrics, where she had oversight of research operations, facilities, financial management practices, research policies, and procedures. The Department's research portfolio spanned bench to bedside with sponsored research expenditures of ~$50M per year. Prior to coming to Stanford, she was a research manager in the medical school at the University of Oxford. She has participated in various University committees and focus groups that aim to improve the quality and management of research programs and is a nationally recognized speaker and faculty member for the National Council of University Research Administrators (NCURA), for which she travels to teach workshops in Departmental Research Administration and Contract Negotiation and Administration.
Angelica Martinez, MPA
Angelica Martinez, MPA currently serves as the Operations Manager for the Center for Definitive and Curative Medicine (CDCM) at Stanford University. Ms. Martinez has more than 15 years of relevant administration, operations, and research coordination experience in research-centered higher education institutions. She is responsible for day-to-day administrative and operational management of the CDCM, acting as key liaison to internal and external partners. Previously, she served as the Associate Director for Administration at the Health Equity Institute, San Francisco State University, where she was responsible for the overall budgetary, hiring, financial, and administrative processes. Ms. Martinez has also served as the Project Director for Gender-Economic Model (GEM) of HIV Risk in African-American and Latina Women at San Francisco State University and as Field Coordinator for the Intergenerational HIV Initiative for Latina Women (also “De Madre a Hija: Protegiendo Nuestra Salud”or “Mija”) at the Center for AIDS Prevention Studies, University of San Francisco, California.
Director of Business Development
Devan Shah has passion for bio-innovation and a background in biotech operations, business development, and investing. He has worked with computational drug discovery companies in executing successful VC-led financings and was most recently VP of Business Operations at a computational pathology company named 3Scan. Previously, he spent time at New Leaf Venture Partners, a healthcare VC firm, where he invested in and analyzed investments in biopharma, medical device, healthcare IT, and diagnostics companies at all stages of the capital cycle (both private and public companies). Devan started his career in the Global Healthcare Group at Citigroup’s Investment Banking Division in New York City.